Cancer vaccine trials and planning for cyber ...

A new non-hormonal drug has been approved to treat menopausal hot flushes. It works by regulating the body's cooling signals and is now available on the NHS in England for those who cannot use hormone replacement therapy. Before delving into the evidence with resident GP Dr Marga ...  Show more

Little over a week on from the first meningitis cases in Canterbury, many crucial questions remain. So this week we're taking an in-depth look at those questions and what we’ve learnt from this outbreak - and could it happen again?James also hears from author Michael Rosen whose ...  Show more

Dr. Pedro Barata and Dr. Lillian Siu discuss recent advances in cancer vaccines and biomarkers, including the potential of the neoantigen and immune modulatory vaccines and the challenges surrounding cancer vaccine development.

<span style= "text-decoration: und ...

All year long, researchers at hospitals around the world collect samples from flu patients and send them to top virology experts with one goal: to design the vaccine for the next flu season. But why do we need a new one every year? Vaccines for diseases like mumps and rubella off ...  Show more

In this nearly 2.5-hour episode, Dr. Rhonda Patrick and Dr. Roger Seheult and Kyle Allred of MedCram make a thoughtful, merit-based, and truly comprehensive discussion of COVID-19 vaccination. In addition to being a co-founder of MedCram Medical Lectures, Dr. Roger Seheult is, as ...  Show more

Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. Immunotherapy stimulates the body's immune system, and can be a powerful treatment for cancer. The most efficient prophylactic cancer vaccine today is the vaccine a ...  Show more